CDIATM HPV 6/11 Rapid Test Kit is intended for the detection of HPV 6/11 antigens in skin or mucocutaneous lesions swab specimens.
Background: Today genital HPV infection is one of the most widespread sexually transmitted diseases. At least 50 percent of sexually active men and women acquire genital HPV infection at some point in their lives. A group of "low-risk" HPVs is typically transmitted through sexual contact, causing genital warts or venereal warts. Over 90% of genital warts are caused by HPV-6 and HPV-11, the so-called "low-risk" HPV types.
Most HPV infections of the genital tract are subclinical and asymptomatic. Subclinical HPV infections may be 10-30 times more common than overt infections. Asymtomatic HPV infections may cause the transmission of HPV and post-treatment recurrences of genital warts. So it is very importan to diagnose the genital warts at early stage, both for symptomatic and asymptomatic patient.
The diagnosis of genital warts now is usually by visual inspection, biopsy, aceto-white application or DNA testing. The sensitivity and specificity of aceto-white application and other clinical diagnostic methods of HPV infection are much lower than the diagnosis based on detection of HPV DNA. But HPV DNA testing needs skilled operator and expensive equipment which limit its use.
CDIATM HPV 6/11 Rapid Test Kit is a simple, rapid and cost-effective diagnostics by detecting the HPV 6 and 11 antigen. It performs well as anaid for the differential diagnosis of genital warts, discovering the subclinical HPV infections and evaluating the risk factors for genital warts post-treatment recurrences.
Accurate: 92.90% sensitivity, 91.2% specificity compared with PCR
Fast: Only 15 minutes required
Easy-to-use: No special equipment required
Room temperature storage